Our News - Care 4 Quality

Class 4 Medicines Defect Information: Morningside Healthcare Limited, Hyoscine Butylbromide 20 mg Film-coated Tablets, EL (22)A/48

November 29, 2022

Morningside Healthcare Limited has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged in batch 22237001 of Hyoscine Butylbromide 20 mg Film-coated Tablets. MDR number MDR 057-11/22 Company name Morningside Healthcare […]

Continue Reading

Class 4 Medicines Defect Information: Macarthys Laboratories t/a Martindale Pharma, Venlafaxine XL 300 mg prolonged-release tablets, EL(22)A/47

November 29, 2022

Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product (Venlalic® XL 300 mg prolonged-release tablets). MDR number MDR […]

Continue Reading

Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46

October 27, 2022

Medreich PLC UK is recalling a batch of Mebeverine hydrochloride 135mg film-coated tablets as a precautionary measure due to out of specification results for tablet dissolution during routine product release testing. MDR Number MDR 130-10/22 […]

Continue Reading

Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets), EL (22)A/43

October 14, 2022

Flamingo Pharma UK Ltd has identified an error relating to the ink printing of the batch number and expiry date on the carton for three batches of Ibuprofen 400mg Tablets. This notification includes all potentially […]

Continue Reading

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41

October 6, 2022

Sanofi is recalling all batches of Stemetil 5mg/5ml Syrup as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit. MDR number MDR 006-09/22 Company name Aventis Pharma Limited (t/a Sanofi) […]

Continue Reading

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

September 14, 2022

Rosemont Pharmaceuticals Ltd. has made the MHRA aware that the expiry dates stamped on the base of the bottle are incorrect for 2 batches of Atorvastatin 4mg/ml Oral Suspension and 2 batches of Sildenafil 10mg/ml […]

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

September 9, 2022

With the CQC’s New Single Assessment Framework launching in 2023, using compliance software ensures your service remains Safe and Well-Led under the sizeable regulatory changes. Using a healthcare-specific compliance software is one great way you […]

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

August 22, 2022

Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in some Rosuvastatin products. MDR Number MDR 197-08/21 Company name Accord Healthcare Limited Product description Rosuvastatin 5 […]

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

July 22, 2022

Novo Nordisk Limited would like to notify you of a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. MDR Number MDR […]

Continue Reading

CQC Release New Quality Statements

July 21, 2022

Here at Care 4 Quality., we deliver exceptional support to healthcare providers nationally to ensure they are fully compliant with the CQC, delivering industry-leading registration support, bespoke policies and procedures, and compliance software. The CQC […]

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

July 15, 2022

We are delighted to be delivering this month’s webinar in collaboration with WorkNest: “Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages” This is taking place on Wednesday 20 […]

Continue Reading

Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29

June 16, 2022

Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping bag label. MDR Number MDR 198-05/22 Company name Altan Pharma Limited Product […]

Continue Reading

CQC New Strategy Webinar– 10 Tips to Remain Compliant from a CQC Inspector

June 9, 2022

In our June webinar, former CQC Inspector Victoria Carey shares her top 10 tips on how you can remain compliant with the CQC as they shift towards a new assessment framework and method of inspection. […]

Continue Reading

Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27

June 1, 2022

Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states strength as 15mg. MDR Number MDR 171-05/22 Company […]

Continue Reading

Class 4 Medicines Defect Information: Orifarm UK Ltd, Loprazolam 1mg Tablets, EL (22)A/25

May 26, 2022

Orifarm UK have informed us of an error with the Patient Information Leaflet (PIL) packaged within the packs of certain batches. The product name stated in the heading of the PIL has been spelt incorrectly […]

Understanding Risk and Compliance in Health and Social Care

Class 4 Medicines Defect Information: Morningside Healthcare Limited, Hyoscine Butylbromide 20 mg Film-coated Tablets, EL (22)A/48

Continue Reading

Class 4 Medicines Defect Information: Macarthys Laboratories t/a Martindale Pharma, Venlafaxine XL 300 mg prolonged-release tablets, EL(22)A/47

Continue Reading

Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46

Continue Reading

Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets), EL (22)A/43

Continue Reading

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41

Continue Reading

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

Continue Reading

CQC Release New Quality Statements

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

Continue Reading

Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29

Continue Reading

CQC New Strategy Webinar– 10 Tips to Remain Compliant from a CQC Inspector

Continue Reading

Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27

Continue Reading

Class 4 Medicines Defect Information: Orifarm UK Ltd, Loprazolam 1mg Tablets, EL (22)A/25

Continue Reading

Request a Callback with Our Specialist Team!

CONTACT US

Care 4 Quality Ltd.

CARE HOME SERVICES & PRICING

TRAINING COURSES

LEGAL